Drug intelligence / Profile preview

baikejing tangjiang

Development stage: Unknown
Lead developer: Liaoning Jindan Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Baikejing Tangjiang is a traditional Chinese medicine (TCM) syrup manufactured by Liaoning Jindan Pharmaceutical. It is an approved pharmaceutical product in China, primarily indicated for the treatment of cough, excessive phlegm, and bronchitis. The formulation is designed to clear heat, resolve phlegm, and relieve cough and asthma. It contains a complex blend of herbal ingredients, including *Stemonae Radix*, *Platycodonis Radix*, *Polygalae Radix*, and *Fritillariae Thunbergii Bulbus*, which provide synergistic antitussive and expectorant effects. The syrup is typically administered orally to soothe the respiratory tract and facilitate the expulsion of mucus.

Brand names: 百咳静糖浆
Other names: Baikejing TangjiangBaikejing Syrup

Beyond the preview

Go deeper on baikejing tangjiang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on baikejing tangjiang.

Explore the full profile